Posted 2 months ago

A Study to Learn How PF-06821497 (Mevrometostat) Works in Men With Metastatic Castration-resistant Prostate Cancer.

ClinicalTrials.gov ID NCT06629779

Protocol number PF 06821497

Sponsor Pfizer